Drugmakers are abandoning cheap generics, and now U.S. cancer patients can't get meds

Scores of drugs to treat cancer, cardiovascular disease and other ailments are in shortage, and experts agree the main cause is the underlying weakness of the generic drug industry.

Related Keywords

California ,United States ,Ahmedabad ,Gujarat ,India ,Petersburg ,Sankt Peterburg ,Russia ,Fredericksburg ,Virginia ,China ,Israel ,America ,Israeli ,Richard Scanlon ,Anthony Sardella ,Satyajit Kosuri ,David Gaugh ,Mark Ratain ,Bonny Moore ,Mark Einstein ,Allan Coukell ,Brent Mcdonald ,Soumi Saha ,Fresenius Kabi ,Robert Califf ,Isabella Mcdonald ,Taylor Swift ,Intas Pharmaceuticals ,Drug Administration ,Washington University In St ,Medicaid Services ,Centers For Medicare ,Intermountain Health ,Pfizer ,Strategic Petroleum ,University Of Chicago ,Washington University ,Health News ,Department Of Obstetrics ,Utah Valley University ,Lannett Co ,Cancer Moonshot ,Stephen Divers ,Hot Springs ,Accessible Medicines ,Accord Healthcare ,Reproductive Health ,Rutgers New Jersey Medical ,Strategic Petroleum Reserve ,